Andi Flory

Study Design and Interim Analysis of the Cancer Lifetime Assessment Screening Study in Canines (CLASSiC): The First Prospective Cancer Screening Study in Dogs Using Next-Generation Sequencing-Based Liquid Biopsy

The paper presents an interim analysis of a canine cancer screening study using NGS-based liquid biopsy, showing increased preclinical cancer detection with OncoK9(R) testing.

Next-generation sequencing-based liquid biopsy can be used for detection of residual disease and cancer recurrence monitoring in dogs

This study evaluates a next-generation sequencing-based liquid biopsy test for detecting residual disease and monitoring cancer recurrence in dogs, finding it can identify recurrence earlier than clinical assessment.

Blood-based liquid biopsy for comprehensive cancer genomic profiling using next-generation sequencing: an emerging paradigm for noninvasive cancer detection and management in dogs

This study shows that blood-based liquid biopsy using next-generation sequencing can detect genomic alterations in dogs with cancer, matching tumor tissue findings and identifying alterations from spatially separated tumor sites.